European safety regulators have launched an investigation into the safety of a batch of the Oxford University/AstraZeneca COVID-19 vaccine, as countries including Denmark suspended its use as a ...
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...
AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...
New inhaled COVID-19 vaccine by McMaster enters phase-2 trials in Canada. The vaccine aims to provide stronger, needle-free ...
AstraZeneca boosts cancer therapies push with ... February 20, 2025 US vaccine advisory meeting postponed after Kennedy takes top health job A meeting of U.S. vaccine advisers set for late ...
In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune ... right patient, right safety and right commercial. ‘Right patient’, for example, is about finding the patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback